[Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospital establishments. Founded in 1909 on a model designed by Marie Curie and still at the forefront, “from fundamental research to innovative care”, the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Cares The Institut Curie Hospital Complex is a reference center for breast cancers, eye tumors and pediatric cancers in particular. The research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians …

Sectors: Health

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Pharmaceutical Companies, brings together companies in the pharmaceutical industry sector in France. Created more than 130 years ago, Leem today has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 professions, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R&D centers, …

Sectors: Startup accelerator & VC

We are dedicated to therapeutic progress to serve patient needs. Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and …

Sectors: Pharmaceutical